Microglandular adenocarcinoma of the endometrium: A form of mucinous adenocarcinoma that may be confused with microglandular hyperplasia of the cervix

International Journal of Gynecological Pathology

Volumn 16, Issue 1, 1997, Pages 52-59

  Zaloudek, Charles ^a   Hayashi, Grant M ^a   Ryan, Isabelle P ^a   Powell, C Bethan ^a   Miller, Theodore R ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Adenocarcinoma; Endometrium; Microglandular hyperplasia; Mucinous adenocarcinoma

Indexed keywords

ADENOCARCINOMA; ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; ENDOMETRIUM BIOPSY; ENDOMETRIUM CARCINOMA; ENDOMETRIUM HYPERPLASIA; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; PRIORITY JOURNAL;

EID: 0030916682     PISSN: 02771691     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004347-199701000-00009     Document Type: Article

References (31)

1. Taylor HB, Irey NS, Norris HJ. Atypical endocervical hyperplasia in women taking oral contraceptives. JAMA 1967;202:637-9.
2. Candy J, Abell MR. Progestogen-induced adenomatous hyperplasia of the uterine cervix. JAMA 1968;203:323-6.
3. Kyriakos M, Kempson RL, Konikov N. Clinical and pathologic study of endocervical lesions associated with oral contraceptives. Cancer 1968;22:99-110.
4. Govan ADT, Black WP, Sharp JL. Aberrant glandular polypi of the uterine cervix associated with contraceptive pills: pathology and pathogenesis. J Clin Pathol 1969;22:84-9.
5. Young RH, Scully RE. Atypical forms of microglandular hyperplasia of the cervix simulating carcinoma: a report of five cases and review of the literature. Am J Surg Pathol 1989;13:50-6.
6. Young RH, Scully RE. Uterine carcinomas simulating microglandular hyperplasia: A report of six cases. Am J Sure Pathol 1992; 16:1092-7.
7. Weidner N, Tjoe J. Immunohistochemical profile of monoclonal antibody O13: antibody that recognizes glycoprotein p30/32MIC2 and is useful in diagnosing Ewing's sarcoma and peripheral neuroepithelioma. Am J Surg Pathol 1994;18:486-94.
8. Leslie KO, Silverberg SG. Microglandular hyperplasia of the cervix: unusual clinical and pathological presentations and their differential diagnosis. Prog Surg Pathol 1984;5:95-114.
9. Dallenbach-Hellweg G, Hahn U. Mucinous and clear cell adenocarcinomas of the endometrium in patients receiving antiestrogens (tamoxifen) and gestagens. Int J Gynecol Pathol 1995;14:7-15.
10. Maes G, Fleuren GJ, Bara J, Nap M. The distribution of mucins, carcinoembryonic antigen, and mucus-associated antigens in endocervical and endometrial adenocarcinomas. Int J Gynecol Pathol 1988;7:112-22.
11. Tsionou C, Minaretzis D, Papageorgiou I, Nakopoulou L, Michalas S, Aravantinos D. Expression of carcinoembryonic antigen and ferritin in normal, hyperplastic, and neoplastic endometrium. Gynecol Oncol 1991;41:193-8.
12. Toki T, Oikawa N, Tase T, Wada Y, Yajima A, Suzuki M. Immunohistochemical localization of carcinoembryonic antigen in adenocarcinoma of the endocervix and the endometrium Tohoku J Exp Med 1985;146:27-32.
13. Cooper P, Russell G, Wilson B. Adenocarcinoma of the endocervix - a histochemical study. Histopathology 1987;11:1321-30.
14. Cohen C, Shulman G, Budgeon LR. Endocervical and endometrial adenocarcinoma: an immunoperoxidase and histochemical study Am J Surg Pathol 1982;6:151-7.
15. Dabbs DJ, Geisinger KR, Norris HT. Intermediate filaments in endometrial and endocervical carcinomas. The diagnostic utility of vimentin patterns. Am J Surg Pathol 1986;10:568-76.
16. Melhem MF, Tobon H. Mucinous adenocarcinoma of the endometrium: a clinico-pathological review of 18 cases, Int J Gynecol Pathol 1987;6:347-55.
17. Osteen KG, Anderson TL, Schwanz K, Hargrove JT, Gorstein F. Distribution of tumor-associated glycoprotein-72 (TAG-72) expression throughout the normal female reproductive tract. Int J Gynecol Pathol 1992;11:216-20.
18. Schwartz AM, Silverberg SG, Fu YS, Nozawa S, Huang S, Tsukasaki K, Williams KR. Use of monoclonal antibodies MSN-1 and B72.3 in the prediction of the natural history of endometrial hyperplasia. Int J Gynecol Pathol 1993;12:253-8.
19. Thor A, Viglione MJ, Muraro R, Ohuchi N, Schlom J, Gorstein F. Monoclonal antibody B72.3 reactivity with human endometrium: a study of normal and malignant tissues, Int J Gynecol Pathol 1987; 6:235-47.
20. Reinartz JJ, George E, Lindgren BR, Niehans GA. Expression of p53. transforming growth factor alpha, epidermal growth factor receptor, and c-erbB-2 in endometrial carcinoma and correlation with survival and known predictors of survival. Hum Pathol 1994-25:1075-83.
21. Bur ME, Perlman C, Edelmann L, Fey E, Rose PG. p53 Expression in neoplasms of the uterine corpus. Am J Clin Pathol 1992;98: 81-7.
22. Inoue M, Fujita M, Enomoto T, Morimoto H, Monden T, Shimano T, Tanizawa O. Immunohistochemical analysis of p53 in gynecologic tumors. Am J Clin Pathol 1994;102:665-70.
23. Sherman ME, Bur ME, Kurman RJ. p53 in endometrial cancer and its putative precursors: evidence for diverse pathways of tumorigenesis. Hum Pathol 1995;26:1268-74.
24. Chumas JC, Nelson B, Mann WJ, Chalas E, Kaplan CG. Microglandular hyperplasia of the uterine cervix. Obstet Gynecol 1985; 66:406-9.
25. Wilkinson E, Dufour DR. Pathogenesis of microglandular hyperplasia of the cervix uteri. Obstet Gynecol 1976;47:189-95.
26. Nichols TM, Fidler HK. Microglandular hyperplasia in cervical cone biopsies taken for suspicious and positive cytology Am J Clin Pathol 1971;56:424-9.
27. Steeper TA, Wick MR. Minimal deviation adenocarcinoma of the uterine cervix ("adenoma malignum"). An immunohistochemical comparison with microglandular endocervical hyperplasia and conventional endocervical adenocarcinoma. Cancer 1986;58: 1131-8.
28. Speers WC, Picaso LG, Silverberg SG. Immunohistochemical localization of carcinoembryonic antigen in microglandular hyperplasia and adenocarcinoma of the endocervix. Am J Clin Pathol 1983;79:105-7.
29. Nanbu Y, Fujii S, Konishi I, Nonogaki H, Mori T. Immunohistochemical localizations of CA 125, carcinoembryonic antigen, and CA 19-9 in normal and neoplastic glandular cells of the uterine cervix. Cancer 1988;62:2580-8.
30. Jacques SM, Qureshi F, Lawrence WD. Surface epithelial changes in endometrial adenocarcinoma: diagnostic pitfalls in curettage specimens. Int J Gynecol Pathol 1995;14:191-7.
31. Nucci MR, Mutter GL, Crum CP. Complex mucinous endometrial proliferations (MEP): subclassification and followup Mod Pathol 1996;9:95A.